ERBB2 and ovarian cancer: synthesized anticancer agents and encapsulated them into nano-LDL particles, the results showed potent anticancer activity against ovarian cancer targeting heat shock protein 27 (HSP27) and human epidermal growth factor receptor 2 (HER2) (Alhadad et al., 2020).